CanadianCannabisWire
CanadianCannabisWire

News and Publishing Service for
Cannabis Related, Canadian Companies

CanadianCannabisWire LimeLight of The MONTH is
 

RYAH Group Inc.
(CSE: RYAH)

View The Complete Profile

RYAH Group Inc. (CSE: RYAH) is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. Through the company’s IoT dose-measuring devices and AI analytics, RYAH is reshaping understanding of the value of devices combined with data, to positively impact the future treatment of patients for various medical conditions.

The company is a leading developer of dose-measuring IoT devices connected with its turn-key platform designed to aggregate and correlate HIPPA-compliant data, suitable to all participants in the patient treatment cycle. The company also specializes in customized, fully integrated, mobile applications and APIs, specifically designed to meet the needs of clinics, clinical trials, government and university research centers, for experimentation and treatment validation – significantly reducing variations in patient-related trials. RYAH unlocks data in the complete therapeutic plant lifecycle – from seed to consumption.

Since it began developing and commercializing its smart inhaler solution in 2018, the company has evolved a complete IoT device and data analytics platform that includes multiple delivery mechanisms, designed to capture anonymous patient dosing and feedback, combined with detailed strain analytics, enabling customized dosing regiments. The company has secured numerous partnerships across the globe, including establishing a footprint in the UK, USA, Australia and Canada, and it has closed several deals in the European Union, as well. The company’s Smart-Inhaler has been selected as the dose-measurement, dose-control and data analytics platform for a UK pain management study and one of the world’s most ambitious and largest clinical trials ever to be conducted in cannabis.

Investment Considerations

  • RYAH Group is a technological leader in the plant-based treatment market with its unique combination of proprietary IoT devices and data analytics, supported by patented AI technology.
  • The company’s products pair a growing ecosystem of therapeutic plants with top-rated apps, devices and services.
  • RYAH offers a complete remote dosage delivery and dose-monitoring platform based on data-driven analytics supported by prescribing doctors and their patients.
  • The company is finalizing its anticipated listing on the Canadian Securities Exchange.
  • RYAH holds a unique position on the $100.3 billion medical plant market, with the potential to capture footholds in both the IoT and Data Intelligence industries.
View More

Receive SMS Text Alerts from CanadianCannabisWire

Text "CCWIRE" to 77948

(US Mobile Phones Only)

Recent Coverage
 

InvestorNewsBreaks - RYAH Group Inc. (CSE: RYAH) Subsidiary Publishes Data Report on Medical Cannabis Use for Pain Management

June 10, 2021 8:30 AM

RYAH Group (CSE: RYAH) announced that its wholly owned subsidiary, RYAH Medtech Inc., has published a data report on the use of medical cannabis among patients with pain conditions. According to the update, the report features insights into the use of cannabis to treat pain conditions by patients within the RYAH Data ecosystem and whether cannabis may be one of the alternative treatment solutions to reduce opioid use-related problems associated with existing treatment options. “The RYAH data report on cannabis use for pain management comes at a turning point as studies on alternatives to opioids in treatment and potential efficacy of chronic pain start to accelerate,” said Gregory Wagner, CEO of RYAH. “The opioid crisis, which began with initially good intentions to more effectively treat pain, created a flood of opioids being prescribed, up from an estimated 70 million prescriptions in the 1990s to more than 255 million by 2012. RYAH is committed to providing the tools needed to effectively monitor and measure dosing in plant-based medicine treatments and to providing data analytics in order for the industry to make more informed decisions around alternative treatments to opioids."

To view the full press release, visit https://ibn.fm/4pBIG

Continue Reading...

About CanadianCannabisWire (CNW)

CanadianCannabisWire (CCW) is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging a professional team of journalists and writers, CCW introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network of over 5,000 key distribution outlets. Cutting through information overload, CCW's innovative and proprietary systems clearly and succinctly deliver its clients much needed visibility, recognition and brand awareness. CCW is where news, content and information converge.

Stay Informed
Bookmark the CCW newsroom page in your favorite browser to stay up to date on all the latest Canadian cannabis news.

See The Latest

Connect With Us
Follow us on social media for the latest news and information from our network of brands and clients.

follow us on twitter  meet on linkedin  like us on facebook

CanadianCannabisWire

CanadianCannabisWire
40 King Street West, Suite 1700-CNW, Toronto, ON M5H 3Y2 (905) 674-5977


Copyright © 2019. All Rights Reserved.

-->